A clinical trial has examined the potential value of TQ in the treatment of Friedreich’s ataxia.
Tuesday, July 4, 2023
Alpha-tocopherylquinone differentially modulates claudins to enhance intestinal epithelial tight junction barrier via AhR and Nrf2 pathways
Ashwinkumar Subramenium Ganapathy, Kushal Saha, Alexandra Wang, Priya Arumugam, Viszwapriya Dharmaprakash, Gregory Yochum, Walter Koltun, Meghali Nighot, Gary Perdew, Todd A. Thompson, Thomas Ma, Prashant Nighot, Alpha-tocopherylquinone differentially modulates claudins to enhance intestinal epithelial tight junction barrier via AhR and Nrf2 pathways, Cell Reports, Volume 42, Issue 7,2023, 112705, doi:10.1016/j.celrep.2023.112705.
Subscribe to:
Posts (Atom)
